Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma

Silvia Pietrobono, Eugenio Gaudio, Sinforosa Gagliardi, Mariapaola Zitani, Laura Carrassa, Francesca Migliorini, Elena Petricci, Fabrizio Manetti, Nikolai Makukhin, Adam G. Bond, Brooke D. Paradise, Alessio Ciulli, Martin E. Fernandez-Zapico, Francesco Bertoni, Barbara Stecca

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences